Senior insider sale
Chief Scientific Officer at SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.4K
689.00 shares
What this filing means
OLSON ERIC R plans to sell 689.00 shares of SYROS PHARMACEUTICALS, INC. valued at approximately $2.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2023ACC: 0001973141-23-000146
Officer· Chief Scientific Officer
Since Feb 2019
689.00
Shares to sell
$2.4K
Approx. market value
689.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit
N/A
3/31/2023
689.00Total acquired689.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2023 | Restricted Stock Unit N/A | 689.00 | — |
| Total | 689.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
689.00
Market value
$2.4K
7/17/2023
Total
Units
689.00
Value
$2.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/17/2023 | 689.00 | $2.4K | NASDAQ | Planned |
| Total | 689.00 | $2.4K | ||